Introduction
The importance of palliative care within urology is being increasingly recognised by the urological establishment following the publication of the Improving Outcomes in Urological Cancers Manual and the Improving Supportive and Palliative Care for Adults with Cancer Manual both published by the National Institute for Clinical Excellence. Achieving a good quality of life for patients and their families and ensuring provision for adequate care of the dying patients within the hospital setting is clearly a goal worth aiming for.
Although not a systematic review, this paper was written with information obtained from original and review journals recently cited in Medline and supplemented with information from The NHS Cancer Plan, the National Institute for Clinical Excellence guidelines, recently published books and finally the authors' own clinical experiences. The authors also discussed the content of the paper with other professionals from Urology and Palliative Care fields.
Epidemiology
Prostate cancer is the second most common cause of cancer deaths in men in the UK. 1 There appears to be a rising trend in incidence of prostate cancer, and it has been predicted that the incidence will soon exceed that of lung cancer. 2 Prostate cancer is often a slowly progressing disease, with patients often living with the morbidity from the disease for many years. Two-thirds of those who die from prostate cancer are over the age of 75 y and 60% of all patients will have advanced disease when first seen. 3 Many of these patients will be symptomatic. 4 Metastatic prostate cancer is incurable and current treatments can result in unpleasant side effects combined with significant morbidity and mortality from the disease itself. Patients are generally elderly, often have concurrent medical problems and suffer from a range of symptoms including progressive painful bone metastases, fatigue and weight loss. 5, 6 In order to help improve the care of patients, the government has recommended that provision of palliative care (both generic and specialist) should be an integral part of patient management in prostate cancer, as set out in the Improving Outcomes in Urological Cancers Manual in the form of NICE guidelines. 6 One of the key recommendations is the management of urological cancers by multidisciplinary urological cancer teams. They point out that patients may require care from specialist cancer treatment teams, specialist Palliative Care teams and Primary Care teams, with the establishment of good communication and information sharing between the teams. These guidelines follow on from the original publication of the Calman-Hine report and the NHS Cancer Plan. Together with the National Cancer Standards in England and the Minimum Standards For Cancer Services in Wales, these important recommendations have been influential in modernising cancer care in the UK. In the foreword of the NICE guidelines manual, Professor Haward stresses the importance of implementing principles of modern cancer care derived from the Calman-Hine report 'y.urological cancer services in general have lagged behind in adopting these principles, although there are encouraging signs that this has begun to change.'
Palliative care
Palliative care (as defined by the World Health Organization) is the active total care of patients whose disease is not responding to curative treatment. Control of pain, of other symptoms and psychological, social and spiritual problems is paramount.
It seeks to help patients achieve and maintain their maximum potential physically, psychologically, socially and spiritually, and improve quality of life of patients and their families over the preceding days, weeks, months or years. 7 It is best delivered by a multiprofessional team, as it is unrealistic for an individual to have all the necessary skills to be able to assess, institute interventions and provide ongoing monitoring. 8 The skills of all the members of a multidisciplinary team are important to clinical decision-making, which is a collective process. 6, 9 Before palliative care was established, terminally ill patients with cancer were often treated with aggressive treatment with curative aim even when they were likely to be futile. Dame Cicely Saunders felt the needs of dying patients were unmet and so founded St Christopher's hospice in London in 1967 to try to address this. A methodical and comprehensive approach was set up to deal with the variety of symptoms and suffering experienced by patients with progressive debilitating disease. Our knowledge about the use and effects of morphine and similar drugs originated at the hospice. 8 Continued research in order to improve our understanding of symptoms and their management is an essential component of modern palliative care. Even though palliative care aims to avoid impersonal care that is overly reliant on technology, progress in the field remains dependent on modern technology and recent advances in molecular biology of pain pathways. Advances in diagnosis and therapeutics including ultrasonography, laparoscopy, CT and MRI imaging, palliative radiotherapy, stent procedures to relieve obstructing lesions as well as the use of drugs such as bisphosphonates for bone pain, all contribute to improved symptom control. 10 Essential to palliative care, however, is to try to understand the whole person, by giving equal attention and consideration to physical, psychosocial and spiritual needs of patients, and to exploring spiritual and existential concerns.
Models of palliative care (Figure 1) Sequential model of palliative care
Palliative care takes over when active treatment ceases. Traditionally resources were allocated to palliative care after aggressive attempts to halt the cancer had failed. However, palliative care is applicable throughout the course of the illness in conjunction with curative treatment, and not just the end of life. Recognising this has led to the emergence of a modern approach to palliative care that is more consistent with the principles of palliative care.
Concurrent model of palliative care
This model focuses on quality and quantity of life ensuring that the patient and his family have access to palliative care network that is traditionally denied them until the last stages of their illness. 11 It is a broadband of care of indeterminate length, beginning with first contact and increasing in importance over the course of the disease, 8, 12 although this will vary with symptomology An investigation into the use of palliative care services by patients with prostate cancer 15 found that a quarter of patients dying of prostate cancer used hospice services, and prostate cancer patients formed the third largest cancer referral group to hospital-based palliative care services. They had the third longest survival time from referral and the oldest age of death of any group. This needs to be an important consideration for raising the profile of palliative care amongst urologists.
Symptoms
Symptomatic prostate cancer that progresses despite optimal hormonal therapy can be extremely disabling. Symptoms include bone pain, bone fractures, fatigue, anorexia, urinary outflow obstruction, anaemia and oedema, coagulation disorders (such as chronic DIC) and spinal cord compression.
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Pain
Patients with advanced cancer commonly experience pain. 18 Pain comprises four main components: physical, psychological, social/financial and spiritual pain, all of which contribute to the 'total pain' suffered by the patient. The physical aspects of pain cannot be treated in isolation, and equally, the patients' anxieties cannot be relieved when the patient is suffering physically. 8 All the various components need to be addressed simultaneously. Psychosocial support may be needed from the time of diagnosis and should be an intrinsic part of caring throughout the course of the illness. Emotional and psychosocial issues not addressed during the early stages of an illness may be more difficult to deal with during the final days of life. The management of incurable disease does not involve tumour regression alone, and side effects of treatments should be balanced against realistic potential outcomes. 19 In order to manage cancer pain, the cause of the pain must be assessed adequately. Some patients have more than one pain with different causes. As prostate cancer is more prevalent in the older age group, due to comorbidities, patients may additionally have pain that is noncancer in origin. An effective assessment and systematic approach to choice of analgesics should be taken. Equal consideration should be given to treating the underlying cause of the pain such as hormonal therapy, radiotherapy, chemotherapy and surgery (see Table 1 ). The focus of care should be on rehabilitation where possible, while setting realistic, achievable goals for pain control. Assurances should be made for relieving at least one aspect of the pain such as pain at night, or during the day at rest, or pain on movement. Unfortunately there is evidence of suboptimal pain management of cancer in the literature. [20] [21] [22] Analgesics (Figure 2) The principles are to aim for simplicity both in choice and route of analgesics, to adjust doses according to individual patient requirements, provide continual medication for continuous pain, make use of adjuvant analgesics effectively and lastly treat side effects of analgesics to allow adequate dose titration. Drugs should be given in standard doses at regular intervals in a stepwise fashion. If a weak opioid is not sufficient, a strong opioid should be substituted. More than one opioid, except for allowing combinations of sustained release and instant release preparations, should not be used simultaneously in the same way that a weak opioid and strong opioid should not be used simultaneously. Even though choice now exists when prescribing strong opioids as new products are developed, morphine still remains the strong opioid of choice. 23 
Gastrointestinal Symptoms
Anorexia is a common symptom of advanced cancer. Megestrol acetate is used commonly to treat a combination of anorexia and fatigue, the effects of which can be Prostate cancer: palliative care and pain relief E Kaya and D Feuer seen after 1-2 weeks of treatment, and appears to be independent of tumour response. 24 Unfortunately, the debate over its evidence remains, with conflicting views in the literature and prescribers often following their own individual preferences. Corticosteroids are an alternative treatment for anorexia and fatigue, 25 but their effect is usually temporary and often subsides after about 4 weeks. Corticosteroids may be the treatment of choice in less ambulatory patients who have a short life expectancy, although they also have an accepted role in antitumour treatment effects. [26] [27] [28] Most patients will be started on 4 mg dexamethasone daily, even though there are no established evidence-based guidelines for doses of corticosteroids. 29 Other symptoms include nausea and constipation, both of which can be effectively treated by a variety of antiemetics and laxatives, respectively.
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Delirium
More than 85% of patients with cancer will experience progressive confusion before death. 30 Causes include opioid analgesics, psychoactive drugs, sepsis, dehydration, renal failure and other metabolic abnormalities. 24 In some cases, simple interventions such as antibiotics, intravenous fluids and treating reversible metabolic abnormalities may be helpful. Confusion secondary to opioids is often accompanied by hallucinations, myoclonic jerks and drowsiness. In such patients, a change to an alternative opioid allows better titration to adequate analgesia while avoiding the accompanying adverse effects. This practice is called 'opioid rotation' and is only recommended with expert advice from specialist palliative care teams. 23 
Approaching death
Despite excellent care of dying patients in hospices 31 there is evidence that this is not the case in hospital. 32 In a recent article in the British Medical Journal, Smith explains ' Most doctors have witnessed patients die undignified, soulless, high tech deaths and hoped for something better for themselves and their patients'. 33 Patients dying on the wards are sometimes seen as failure. In fact, achieving a good death for our patients should be viewed as successful medicine. Practitioners need to be aware of the many barriers that get in the way of a good death, such as lack of training, their own fears of mortality and past experiences all of which can lead to distancing and isolation of the patient. 32 Care of dying patients should be a priority and social, cultural and spiritual/religious backgrounds of patients should be acknowledged and taken into consideration with care planning.
An important first step is the ability to recognise dying. Increasing weakness and immobility, drowsiness, difficulty swallowing and reduced intake of food and drink are signs and symptoms that patients experience during the last stages of life. 34, 35 It is important to recognise dying as early as possible as doctors are known to overestimate survival in terminally ill patients with cancer. 36 and in some cases the patients and carers may not always have had time to prepare for approaching death. The Liverpool Integrated Care Pathway for the Dying was developed as a model of good care for patients dying in hospices, hospitals, nursing homes and the community. It was based on models of best practice in the hospice setting and was further adapted for the hospital setting. This multidisciplinary model has since been incorporated into the cancer collaborative programme. 34 There are three parts to the pathway: initial assessment and care, ongoing care, and bereavement. All nonessential drugs whose side effects no longer justify any potential benefits should be discontinued, the number of investigations limited with greater importance on clinical observations, and good symptom control maintained throughout care. This will be a national requirement for all trusts in the coming years. 13 
Goals
THE NHS CANCER PLAN 2000 highlights important issues-'providing the best possible care for dying patients remains of paramount importance. Too many patients still experience distressing symptoms, poor nursing care, poor psychological and social support and inadequate communication from health care professions during the final stages of an illness. The care of all dying patients must improve to the level of the best. ' A valuable resource of educational material on palliative care is available in books and journals. Unfortunately, textbooks, journals and meetings for urology devote a disproportionately small amount of space and time to palliative care. Reducing barriers to palliative care, improving education and attitudes of the medical and nursing professions will all contribute to raising the profile of palliative care 37 and improve opportunities for research in the field.
We hope that principles of palliative care are accepted and practised by all professionals, that specialist palliative care is available to all, and the principles of palliative care are taught and examined, within a well-managed integrated service.
